High-dose PPI changes ‘effective’: PBAC

Decrease in esomeprazole and increase in pantoprazole scripts likely due to restriction changes, says PBAC, though full picture obscured by lack of OTC and private data Restriction changes established in 2019 have been successful at reducing use of high-dose PPIs by moving patients to lower-dose PPIs, the PBAC said in response to data recently provided

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Temporary rego extendable
Next Reduce or run out